The Effects of Thiazolidinediones on Metabolic Complications and Lipodystrophy in HIV-Infected Patients

The Effects of Thiazolidinediones on Metabolic Complications and Lipodystrophy in HIV-Infected Patients

Saved in:

Bibliographic Details
Main Author:	Jussi Sutinen
Format:	Article
Language:	English
Published:	Wiley 2009-01-01
Series:	PPAR Research
Online Access:	http://dx.doi.org/10.1155/2009/373524
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antiretroviral-Related Adipocyte Dysfunction and Lipodystrophy in HIV-Infected Patients: Alteration of the PPARγ-Dependent Pathways
by: Martine Caron, et al.
Published: (2009-01-01)

Cutis Verticis Gyrata in Men Affected by HIV-Related Lipodystrophy
by: Keshav Khanijow, et al.
Published: (2013-01-01)

Bioplastia na lipodistrofia de pacientes com HIV/AIDS Bioplasty for lipodystrophy in patients with HIV/AIDS
by: Marilho Tadeu Dornelas, et al.
Published: (2012-09-01)

Deciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer
by: Melody Chiu, et al.
Published: (2017-01-01)

Lipodystrophy of Abdominal Pannus: A Severe Complication of Phosphatidyl Choline Injections
by: Parag S. Telang
Published: (2021-04-01)

HIV facial lipodystrophy treatment by polylactic acid – a literature review
by: Adam Solarz, et al.
Published: (2024-11-01)

Effects of switching from stavudine to raltegravir on subcutaneous adipose tissue in HIV-infected patients with HIV/HAART-associated lipodystrophy syndrome (HALS). A clinical and molecular study.
by: Pere Domingo, et al.
Published: (2014-01-01)

Neuroprotective Effect and Mechanism of Thiazolidinedione on Dopaminergic Neurons In Vivo and In Vitro in Parkinson’s Disease
by: Yanqin Wang, et al.
Published: (2017-01-01)

Lipodystrophy induced by combination antiretroviral therapy in HIV/AIDS patients: A Belgrade cohort study
by: Dragović Gordana, et al.
Published: (2014-01-01)

HIV-associated lipodystrophy: epidemiological analysis of a Plastic Surgery Service in Brazil
by: Murilo Sgarbi Secanho, et al.
Published: (2023-05-01)

Partial lipodystrophy with renal disorder
by: Y Saraçlar, et al.
Published: (1972-01-01)

Brazilian expert consensus on the diagnosis, classification, screening for complications and treatment of familial partial lipodystrophy
by: Cynthia Melissa Valerio, et al.
Published: (2025-06-01)

Design, Synthesis, Antihyperglycemic Studies, and Docking Simulations of Benzimidazole-Thiazolidinedione Hybrids
by: Abraham Gutierréz-Hernández, et al.
Published: (2019-01-01)

Scleredema in a Patient with AIDS-Related Lipodystrophy Syndrome
by: Ralph Yachoui, et al.
Published: (2013-01-01)

Acquired lipodystrophy following use of pembrolizumab
by: Maya Weitzen, et al.
Published: (2024-12-01)

Giant fibrolipoma mimicking abdominal lipodystrophy
by: Kenan Yusuf Coban, et al.
Published: (2008-01-01)

The risk of fractures associated with thiazolidinediones: a self-controlled case-series study.
by: Ian J Douglas, et al.
Published: (2009-09-01)

The impact of dermolipectomy in improving the quality of life in patients with abdominal lipodystrophy
by: Marilia de Pádua Dornelas Correa, et al.
Published: (2016-06-01)

Causes of death in patients with Berardinelli-Seip congenital generalized lipodystrophy.
by: Josivan Gomes Lima, et al.
Published: (2018-01-01)

Thiazolidinedione Use and Cardiovascular Outcomes in Patients With Type 2 Diabetes Who Underwent Carotid Artery Revascularization
by: Jun Hwee Kim, et al.
Published: (2025-04-01)

Current Advances in the Biochemical and Physiological Aspects of the Treatment of Type 2 Diabetes Mellitus with Thiazolidinediones
by: D. Alemán-González-Duhart, et al.
Published: (2016-01-01)

A very low carbohydrate diet improved metabolic profile in congenital generalized lipodystrophy type 4
by: Sayantan Chakraborty, et al.
Published: (2025-01-01)

Psoriasis Risk Is Lower in Type 2 Diabetes Patients Using Dipeptidyl Peptidase‐4 Inhibitors or Thiazolidinediones Compared to Sulfonylureas
by: Wei‐Sheng Chen, et al.
Published: (2025-03-01)

Design and synthesis of a novel quinoline thiazolidinedione hybrid as a potential antidiabetic PPARγ modulator
by: Ayman M. Ibrahim, et al.
Published: (2025-06-01)

CADD based designing and biological evaluation of novel triazole based thiazolidinedione coumarin hybrids as antidiabetic agent
by: Anchal Sharma, et al.
Published: (2025-02-01)

Congenital generalized lipodystrophy: Berardinelli syndrome. Report of two siblings
by: F Gürakan, et al.
Published: (1995-07-01)

The clinical approach to child and adolescent patients with lipodystrophy: a series of international case discussions
by: Rebecca J. Brown, et al.
Published: (2025-08-01)

Large-volume liposuction in acquired partial lipodystrophy: a case report
by: Yasiru Gehan Karunaratne, et al.
Published: (2019-09-01)

Combination of familial partial lipodystrophy (Dunnigan-Cobberling syndrome) with pulmonary sarcoidosis
by: N. V. Frolkova, et al.
Published: (2024-07-01)

Lipodystrophy at the insulin injection sites: current trends in epidemiology, diagnostics and prevention
by: Vadim V. Klimontov, et al.
Published: (2020-06-01)

HIV INFECTION AND CARDIOVASCULAR COMPLICATIONS
by: S. S. Yakushin, et al.
Published: (2014-07-01)

Hyperandrogenism as a clinical manifestation of familial partial lipodystrophy type 2 in an adolescent female patient
by: Ewa Błaszczyk, et al.
Published: (2025-03-01)

Complicated giant duodenal ulcer in the HIV-infected patient
by: V. L. Poluektov, et al.
Published: (2019-06-01)

A real-world pharmacovigilance assessment and literature review of lymphoma development in lipodystrophy
by: Rebecca J. Brown, et al.
Published: (2025-05-01)

Effect of SGLT2 inhibitors on thiazolidinedione-induced changes in the volume status of patients with type 2 diabetes mellitus: a 6-month follow-up prospective study
by: Yagmur Busra Unlusoy, et al.
Published: (2025-08-01)

Prevalence of clinical characteristics of lipodystrophy in the US adult population in a healthcare claims database
by: Seonkyeong Yang, et al.
Published: (2024-07-01)

Preclinical evaluation of candidate “kill or cure” strategies to treat MFN2-related lipodystrophy
by: Ineke Luijten, et al.
Published: (2025-08-01)

Hemophagocytic Lymphohistiocytosis Complicating T-Cell Lymphoma in a Patient with HIV Infection
by: Marc Uemura, et al.
Published: (2013-01-01)

Synergistic benefit of thiazolidinedione and sodium-glucose cotransporter 2 inhibitor for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a 24-week, open-label, randomized controlled trial
by: Minyoung Lee, et al.
Published: (2025-05-01)

Neuroanatomical characterisation of the expression of the lipodystrophy and motor-neuropathy gene Bscl2 in adult mouse brain.
by: Alastair S Garfield, et al.
Published: (2012-01-01)